GlassScriptPhysician profile
Erika Koredjian
NPI 1194550632
$628.63
in general payments reported to CMS, 2019-2025
10 companies · $590 in 2025
The $590 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $38.35 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $173.70 | 2025 | Cabenuva, Rukobia, Dovato |
| Paratek Pharmaceuticals, INC. | $128.76 | 2024-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $104.67 | 2025 | Pifeltro, Capvaxive |
| Abbvie INC. | $77.47 | 2025 | |
| Theratechnologies INC. | $39.22 | 2025 | Egrifta, Trogarzo |
| Pfizer INC. | $27.03 | 2025 | |
| Melinta Therapeutics, LLC | $24.23 | 2025 | Rezzayo, Orbactiv, Kimyrsa |
| Insmed, INC. | $19.15 | 2025 | Arikayce |
| La Jolla Pharmaceutical Company | $18.34 | 2025 | |
| Pharming Healthcare, INC. | $16.06 | 2025 | Ruconest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Koredjian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.